The multinational pharmaceutical company Sanofi is an example of win-win cooperation between China and France, as it fosters technology transfer while improving access to essential treatments and medical solutions for both countries, said the company's Greater China chief financial officer (CFO) in Chengdu City, southwest China's Sichuan Province.
This year marks the 60th anniversary of China-France diplomatic relations, with ties between the two countries in the spotlight as Chinese President Xi Jinping will pay a state visit to France next week.
Over the past 60 years, China and France have seen huge growth in bilateral trade and mutual direct investment.
In a recent interview with China Global Television Network (CGTN), Charles Billiard, CFO of Sanofi Greater China, discussed how Sanofi is navigating the Chinese market and exploring partnership opportunities.
"We will have other things happening in this year of the 60th anniversary. But I think Sanofi is very much one of the examples of what this friendship between China and France can mean, with mutual win-win developments where Sanofi is benefiting from the very big market in China, from innovation in China. And of course, China is also benefiting from Sanofi innovation as well as other products, which is why, for instance, we try to accelerate the submission and launch of all our products in China to make it available to Chinese patients at the same time as any other developed market like the U.S. or Europe," he said.
CFO of French pharmaceutical giant lauds China-France win-win cooperation
